Drug Profile
Influenza vaccine - Centivax
Alternative Names: Centivax Flu; Centivax Flu vaccineLatest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Distributed Bio
- Developer Centivax
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in USA (Parenteral)
- 06 May 2021 Centivax plans a clinical trial for Influenza virus infections in 2024 (Centivax pipeline, May 2021)
- 21 Dec 2017 Preclinical trials in Influenza virus infections (Prevention) in USA (Parenteral) before December 2017 (Distributed Bio pipeline, December 2017)